Here, we present the crystal structure of the human tetrameric SAMHD1-dGTP complex. The structure reveals an elegant allosteric mechanism of activation through dGTP-induced tetramerization of two inactive dimers. Binding of dGTP to four allosteric sites promotes tetramerization and induces a conformational change in the substrate-binding pocket to yield the catalytically active enzyme. Structure-based biochemical and cell-based biological assays confirmed the proposed mechanism. The SAMHD1 tetramer structure provides the basis for a mechanistic understanding of its function in HIV restriction and the pathogenesis of AGS. npg
a r t i c l e s
The sterile alpha motif and HD domain-containing protein 1 (SAMHD1) dNTPase has dual roles in human innate immunity. It restricts HIV-1 infection in immune cells of myeloid lineage and in quiescent CD4-positive T lymphocytes [1] [2] [3] [4] [5] . In these nondividing cells, SAMHD1 reduces cellular dNTP levels to concentrations below the threshold required for reverse transcription of the viral RNA genome into DNA [6] [7] [8] . Furthermore, mutations in SAMHD1 are associated with an autoimmune condition, AGS 9,10 , whose clinical manifestations resemble congenital viral infection 11, 12 . AGS-associated SAMHD1 mutations appear to disrupt the dNTPase activity of SAMHD1. Thus, SAMHD1's ability to negatively regulate cellular dNTP levels is essential for its roles in innate immunity 13, 14 .
The dNTPase activity of SAMHD1 resides in its histidineaspartate (HD) domain, with the N-terminal sterile alpha motif (SAM) domain involved in other activities [13] [14] [15] [16] [17] . A recent crystal structure of a dimeric SAMHD1 catalytic-core fragment (SAMHD1c1, residues 120-626) suggested an allosteric, dGTP-stimulated mechanism for the promotion of the dNTPase activity of dimeric SAMHD1 (ref. 14) . However, the SAMHD1c1 structure did not contain substrate or the dGTP cofactor, thus providing limited insight into the mechanism of SAMHD1 activation. Recent biochemical and functional studies revealed that SAMHD1 interconverts between an inactive monomeric or dimeric form and a dGTP-induced tetrameric form that is the active dNTPase that restricts HIV 15, 18 .
To elucidate the mechanism of dGTP-induced oligomerization and allosteric activation of SAMHD1, we determined the crystal structure of the tetrameric SAMHD1-dGTP complex. The structure revealed two dGTP molecules in each of the four allosteric sites of the SAMHD1 tetramer. Comparison of the apo-SAMHD1 dimer with the SAMHD1-dGTP tetramer structures showed large, allosteric dGTPinduced conformational changes at the tetramer interfaces and the catalytic sites nearby, thus enabling the binding of the dNTP substrates. We validated the importance of the residues involved in these changes by using biochemical and cell-biological assays. Together, our results provide mechanistic insights into dGTP-induced allosteric regulation of the catalytic function of SAMHD1.
RESULTS
To investigate the allosteric activation of SAMHD1 by dGTP, we determined the crystal structure of the human SAMHD1 catalytic core (SAMHD1c2, residues 113-626) bound to dGTP ( Fig. 1 and Table 1 ). SAMHD1c2 undergoes dGTP-dependent tetramerization and activation similarly to the full-length wild-type protein 15 . To prevent substrate hydrolysis, we used the substrate analog α-thio-dGTP (dGTPαS) to trap the complex in the substrate-bound conformation and determined the dGTPαS-SAMHD1c2 structure at 2.9-Å resolution. In addition, we solved the structure of a catalytically inactive mutant, SAMHD1c2-RN (H206R D207N), with bound dGTP at 1.8-Å resolution. The two structures are virtually identical (r.m.s. deviation 0.53 Å), except that the mutant complex does not contain the catalytic metal ion, owing to substitution of the conserved metal-coordinating residues H206 and D207 by arginine and asparagine, respectively. For clarity, we refer to the structures as the dGTP-SAMHD1c2 complex when describing identical features in both structures. The overall structure comprises a welldefined catalytic core, with no density observed for only a short loop region (residues 278-283) and the C terminus (residues 600-626). a r t i c l e s The structure of the dGTP-induced SAMHD1 tetramer One SAMHD1c2 tetramer of 222 point-group symmetry ( Fig. 1a,b ; subunits labeled A, B, C and D) is in the asymmetric unit of the crystal. The AD and BC dimer structures are similar to the previously reported dimer structure of SAMHD1c1, burying 1,750 Å 2 surface area per subunit at the dimer interface. These AD and BC interfaces are referred to as the dimer-1 interfaces in the following discussion. Two dimers associate further and form a very tight tetramer, thus resulting in a buried dimer-dimer interface of 4,920 Å 2 . The tetramerization is mediated mainly by the newly formed interfaces between A and C and between B and D. We refer to the AC and BD interfaces as the dimer-2 or tetramer interfaces. The subunits in the tetramer exhibit a virtually identical conformation, which is notably different from that in the dimeric SAMHD1c1 structure ( Fig. 1c and Supplementary Fig. 1a ). In particular, we observed a large conformational change at the new dimer-2 or tetramer interface ( Fig. 1d) . Tetramerization causes ordering of over 40 residues (residues 506-515, 531-547 and 584-599) that display clear density in the dGTP-SAMHD1c2 structure, whereas these residues were not observed in the previous SAMHD1c1 structure ( Fig. 1b-d and Supplementary  Fig. 1 ). These residues are critical for the formation of the SAMHD1 tetramer (discussed below).
The most striking feature in the SAMHD1c2 tetramer structure is the presence of 12 dGTP molecules. There are two dGTPs bound to each of the four allosteric sites and one dGTP bound to each of the four catalytic sites (Fig. 1b) . Each allosteric dGTP-binding site is located at an interface of three subunits, thus highlighting the importance of dGTP for mediating the tetramer structure ( Fig. 2a) . This structural result agrees well with our solution biochemical data of dGTP-induced tetramerization 15 . Notably, residues 113-119 form a critical part of the allosteric dGTP-binding pocket ( Figs. 1c and 2a) , thus explaining why SAMHD1c1, which lacks these residues, crystallized only as a dimer 14 .
dGTP-Mg 2+ -dGTP binding at the allosteric site of SAMHD1
The allosteric dGTPs interact with an extensive network of hydrogen-bonding residues and exhibit excellent shape and size complementarity with the binding pocket at a three-subunit interface ( Fig. 2a) . Because all four allosteric dGTP-binding sites are identical, we selected the ACD interface for discussion of interactions. One of the two dGTPs (designated dGTP-1) interacts with residues D137, Q142 and R145 of subunit D, forming five hydrogen-bonding interactions with the Watson-Crick and the Hoogsteen (N7) sites of the G base. The second allosteric dGTP (designated as dGTP-2) interacts at the Watson-Crick base sites with residues N358 and D330 of subunit C. In addition, numerous residues from subunits A (V156, H376, K377, R451 and K455), C (R333, R352, K354 and K523) and D (K116 and N119) provide additional hydrogen-bonding and stacking interactions with the base, sugar and triphosphate moieties of the two allosteric dGTPs ( Fig. 2b and Supplementary Fig. 2 ). Any other base in this pocket would result in fewer hydrogen bonds or in steric hindrance in the binding site. This provides a clear structural rationale for the inability of other dNTPs to activate SAMHD1 (ref. 14) . The size of the dGTP-binding pocket provides a snug fit to the deoxyribose ring, leaving little room for the 2′-hydroxyl group of a ribose of GTP ( Supplementary Fig. 3a) .
The two allosteric dGTPs are juxtaposed with a Mg 2+ ion bridging their phosphate groups in a dGTP-Mg 2+ -dGTP configuration ( Fig. 2a and Supplementary Fig. 3b) , and four such dGTP pairs at the four allosteric sites interlock the subunits in the SAMHD1 tetramer. npg a r t i c l e s Each pair accounts for a buried surface of ~900 Å 2 between the dGTPs and the three associated polypeptide chains. The magnesium ion is coordinated by five oxygen atoms of the β-γ phosphate groups of two dGTP molecules and one ordered water molecule in an octahedral geometry ( Supplementary Fig. 3b ). The unique dGTP-Mg 2+ -dGTP pairing noted here has not been previously observed in the oligomerization and allosteric activation of other HD domaincontaining proteins [19] [20] [21] .
Tetramerization causes conformational changes of SAMHD1
The dGTP-mediated tetramerization induces a large conformational change in SAMHD1 in regions at the tetramer interfaces when compared with the SAMHD1c1 dimer ( Fig. 1c,d) . Three layers of symmetrical protein contacts around a two-fold symmetry axis are formed between the subunits at the dimer-2 interface (Fig. 2c) . The first layer forms an S-shaped interlocking interface on the surface of the tetramer (Figs. 1a and 2d) . This interface involves the C-terminal region of the protein (residues 454-599) with a loop-turn-loop structure (residues 506-515 and 531-547, disordered in SAMHD1c1) inserting into the concave surface of the two-fold-symmetrically related neighbor. This surface also contains another region at the C terminus of the structure (residues 584-599) that is disordered in the SAMHD1c1 dimer. The second layer of interaction involves a long α-helix (residues 352-373) whose C terminus is sandwiched between the catalytic site and the allosteric dGTP-2 ( Fig. 2e) . The orientation of this helix in the tetramer is different from that in the SAMHD1c1 dimer, probably enabling crucial interactions required for the activation of the enzyme (discussed below). The third layer of interaction resides in the center of the tetramer with a loop-helix region (residues 325-333) engaging in direct protein-protein contacts as well as contacts to dGTP-2 ( Fig. 2f) . This further demonstrates the critical role that dGTP has in SAMHD1 tetramerization.
Phosphorylation of SAMHD1 residue T592 has been reported recently as a key regulator of its antiviral function 22, 23 . The phosphorylation is catalyzed by the cell-cycle regulator cyclin A2-CDK1 upon recognition of the target motif (592-TPQK-595) on SAMHD1 (refs. [22] [23] [24] . Our structure shows that T592 resides in the newly ordered C-terminal region whose structure is stabilized by tetramerization (Fig. 2d) . The 592-TPQK-595 motif is close to the tetramer interface and is solvent exposed (Supplementary Fig. 4 ). Modeling of a phosphate group onto T592 suggests that phosphorylation does not affect tetramerization or the folding of the protein. This is consistent with the finding that phosphorylation of T592 does not change the dNTPase activity of SAMHD1 (refs. 22,23) .
Tetramer-disrupting mutations abolish SAMHD1 function
We carried out mutagenesis studies to verify that the contacts with the allosteric dGTPs and the associated tetramerization are important. Residue changes such as R333A, D330A N358A and R352A H376A K377A reduced dGTP-induced tetramerization and dNTPase activity in vitro, as well as dNTPase and antiviral activities in vivo (Fig. 3) . The importance of the dGTP-binding residue D137 is supported by previous reports that the D137A mutation abolished SAMHD1 catalytic activity and dGTP-dependent tetramerization 14, 15 . Similarly, changing residues engaged in the interactions along the tetramer interfaces, such as D361R H364K and K534E V537D L540D, abolished tetramerization and impaired hydrolysis of dNTP in vitro (Fig. 3a,b) . These mutants were also unable to restrict HIV-1 and deplete dNTP pools when expressed in cells ( Fig. 3c,d) .
Tetramerization of SAMHD1 activates the enzyme
In addition to the dGTP-Mg 2+ -dGTP bound at the allosteric sites, one dGTP molecule is bound in the catalytic site of each SAMHD1c2 subunit (Fig. 4a) . The substrate-binding pocket is located near the dimer-2 interface, with the interface α-helix (residues 352-373) ( Fig. 2e) lining one side of the pocket (Fig. 4a,b) . The other side of the binding pocket is close to the dimer-1 interface observed previously 14 and contains the canonical histidine and aspartate (HD) residues required for catalysis 21 (Fig. 4c) . A catalytic metal ion is coordinated by the side chains of residues H167, H206, D207 and D311, and the oxygen of the α-phosphate group of the substrate ( Supplementary  Fig. 5) . Comparison of the current dGTP-SAMHD1c2 structure with that of a homologous protein, EF1143 from Enterococcus fecalis (PDB 3IRH) 19 , suggests that H210, H233 and D218 are the catalytic residues (Supplementary Fig. 5 ). The extensive network of interactions within the snug binding pocket orients dGTP for catalysis ( Supplementary  Fig. 5 ). NTPs are excluded as substrates because the 2′-hydroxyl group of a ribose would clash with residues L150 and Y374 in the pocket. Notably, the extra space and lack of specific interactions at the base edge result in the ability of SAMHD1 to accommodate all four dNTPs as substrates (Supplementary Fig. 5) .
The dGTP-induced tetramerization and conformational change alter the size and shape of the substrate-binding pocket in the inactive dimer to enable dNTP binding by SAMHD1 (Fig. 4c) . Little change appears at the dimer-1 interface, while large structural rearrangements occur at the dimer-2 interface in SAMHD1c2 compared to SAMHD1c1 (Figs. 4a and 1d) . A more open pocket in the inactive dimer closes up upon tetramerization, enclosing the dNTP substrate ( Fig. 4c) . Specifically, the α-helix sandwiched between the catalytic Two crystals for the H206R D207N SAMHD1c2 structure and one crystal for the wildtype SAMHD1c2 structure were used for data collection and structure determination. npg a r t i c l e s with Y315 and R366 contacts the γ-phosphate group of dGTP ( Fig. 4b) . Mutation of these residues (K312A Y315A R366A or H370A Y374G) abolished the catalytic activity of SAMHD1 ( Fig. 4d) , presumably because they are important for binding and orienting the dGTP substrate for catalysis.
DISCUSSION
SAMHD1 has been identified as an HIV-restriction factor in nondividing cells, and the allosteric dGTP-mediated dNTPase activity is key to its antiviral function. However, the mechanism of allosteric activation of SAMHD1 was unknown. In particular, how allosteric dGTP induces the tetramerization of SAMHD1 and subsequently enables substrate-dNTP binding and catalysis remained mysterious. The work presented here establishes the structural and biochemical basis for the catalytic mechanism of SAMHD1 ( Fig. 5) : in the absence of the dGTP cofactor, SAMHD1 exists as an inactive monomer or dimer, in which the substrate-binding pocket is unable to bind dNTP 15, 18 . Upon binding of dGTP-Mg 2+ -dGTP at the allosteric sites, the catalytically inactive SAMHD1 dimers tetramerize, thus inducing a large conformational change at the tetramer interface. This conformational change is transferred to the catalytic sites nearby, and this results in a change of the size and shape of the substrate-binding pocket. It is possible that, once activated, the SAMHD1 tetramer can perform multiple catalytic cycles that enable dNTP to bind in a catalytically productive conformation without having to go through the dimer-tetramer transition and associated conformational changes in each cycle. This is supported by our previous biochemical data showing that SAMHD1 tetramers are stable in the presence of dGTP 15 . The antiviral activity of SAMHD1 is downregulated by phosphorylation at residue T592 by cyclin A2-CDK1 kinase, thus resulting in inhibition of HIV infection only in nondividing cells such as quiescent CD4-positive cells, macrophages and dendritic cells [1] [2] [3] [4] . Our structural result shows that the 592-TPQK-595 motif is solvent exposed on the protein surface and that phosphorylation is unlikely to affect the active conformation of the enzyme. This is consistent with the observation that phosphorylation of SAMHD1 does not influence its dNTPase activity 22 . Besides the dNTPase activity, SAMHD1 has also been implicated in nucleic acid binding and exonuclease activity 16, 25, 26 , and this allows for the possibility that phosphorylation of T592 affects other activities of SAMHD1 required for retroviral restriction. Alternatively, T592 phosphorylation could modulate the interaction between SAMHD1 and an unknown cellular cofactor, which, in turn may influence the activities of SAMHD1. Further detailed studies are needed to elucidate the regulatory effect of SAMHD1 phosphorylation.
The loss-of-function mutations of SAMHD1 also lead to the autoinflammatory syndrome AGS 10 . Previous studies revealed that some of the AGS-linked SAMHD1 mutations disrupt the catalytic site (R143H/C and G209S). Our current structure now illustrates how other mutations such as those residing at the allosteric dGTPbinding sites (R145Q, H123P, ∆120-123 and M385V) or at the tetramer interfaces (L369S) interfered with SAMHD1 function. Overall, our results provide compelling evidence for the biological relevance of the SAMHD1 tetramer and offer a biochemical and structural basis for understanding SAMHD1 functions in the pathogenesis of both HIV infection and AGS.
Our structural results not only provide mechanistic insights into the regulation of SAMHD1 but also inform on the broad class of HD domain-containing allosteric phosphohydrolases that oligomerize npg a r t i c l e s and are activated upon NTP or dNTP binding 19, 20, [27] [28] [29] . For these HD enzymes, it has been an open question how ligand binding at an allosteric site induces their activation. Our current structure suggests an elegant general mechanism, namely the creation of an active enzyme by dNTP or NTP-induced oligomerization and reshaping of the substrate-binding pocket adjacent to the newly formed molecular interface ( Figs. 4c and 5) .
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Coordinates and structural factors have been deposited in the Protein Data Bank under accession codes 4BZC for the wild type and 4BZB for the RN mutant.
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